208 related articles for article (PubMed ID: 23142783)
41. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
42. Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A.
Scalia P; Heart E; Comai L; Vigneri R; Sung CK
J Cell Biochem; 2001; 82(4):610-8. PubMed ID: 11500939
[TBL] [Abstract][Full Text] [Related]
43. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
44. Calcineurin B homologous protein 3 negatively regulates cardiomyocyte hypertrophy via inhibition of glycogen synthase kinase 3 phosphorylation.
Kobayashi S; Nakamura TY; Wakabayashi S
J Mol Cell Cardiol; 2015 Jul; 84():133-42. PubMed ID: 25935310
[TBL] [Abstract][Full Text] [Related]
45. Regulation of the PI3K/AKT Pathway and Fuel Utilization During Primate Torpor in the Gray Mouse Lemur, Microcebus murinus.
Tessier SN; Zhang J; Biggar KK; Wu CW; Pifferi F; Perret M; Storey KB
Genomics Proteomics Bioinformatics; 2015 Apr; 13(2):91-102. PubMed ID: 26092184
[TBL] [Abstract][Full Text] [Related]
46. Probing the PI3K/Akt/mTor pathway using
Phyu SM; Tseng CC; Fleming IN; Smith TA
Sci Rep; 2016 Nov; 6():36544. PubMed ID: 27811956
[TBL] [Abstract][Full Text] [Related]
47. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome.
Tapodi A; Bognar Z; Szabo C; Gallyas F; Sumegi B; Hocsak E
Biochem Pharmacol; 2019 Apr; 162():98-108. PubMed ID: 30296409
[TBL] [Abstract][Full Text] [Related]
48. The imbalance of Treg/Th17 cells induced by perinatal bisphenol A exposure is associated with activation of the PI3K/Akt/mTOR signaling pathway in male offspring mice.
Gao L; Dong Y; Lin R; Meng Y; Wu F; Jia L
Food Chem Toxicol; 2020 Mar; 137():111177. PubMed ID: 32028014
[TBL] [Abstract][Full Text] [Related]
49. Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling.
Bénard L; Oh JG; Cacheux M; Lee A; Nonnenmacher M; Matasic DS; Kohlbrenner E; Kho C; Pavoine C; Hajjar RJ; Hulot JS
Circulation; 2016 Apr; 133(15):1458-71; discussion 1471. PubMed ID: 26936863
[TBL] [Abstract][Full Text] [Related]
50. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.
Nair VD; Olanow CW
J Biol Chem; 2008 May; 283(22):15469-78. PubMed ID: 18387957
[TBL] [Abstract][Full Text] [Related]
51. Activation of protein kinase C-ζ in pancreatic β-cells in vivo improves glucose tolerance and induces β-cell expansion via mTOR activation.
Velazquez-Garcia S; Valle S; Rosa TC; Takane KK; Demirci C; Alvarez-Perez JC; Mellado-Gil JM; Ernst S; Scott DK; Vasavada RC; Alonso LC; Garcia-Ocaña A
Diabetes; 2011 Oct; 60(10):2546-59. PubMed ID: 21911744
[TBL] [Abstract][Full Text] [Related]
52. GSK3β, but not GSK3α, inhibits the neuronal differentiation of neural progenitor cells as a downstream target of mammalian target of rapamycin complex1.
Ahn J; Jang J; Choi J; Lee J; Oh SH; Lee J; Yoon K; Kim S
Stem Cells Dev; 2014 May; 23(10):1121-33. PubMed ID: 24397546
[TBL] [Abstract][Full Text] [Related]
53. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
54. Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation.
Lee CJ; Jang JH; Lee JY; Lee MH; Li Y; Ryu HW; Choi KI; Dong Z; Lee HS; Oh SR; Surh YJ; Cho YY
Carcinogenesis; 2015 Oct; 36(10):1223-34. PubMed ID: 26243309
[TBL] [Abstract][Full Text] [Related]
55. Dual regulation of glycogen synthase kinase 3 (GSK3)α/β by protein kinase C (PKC)α and Akt promotes thrombin-mediated integrin αIIbβ3 activation and granule secretion in platelets.
Moore SF; van den Bosch MT; Hunter RW; Sakamoto K; Poole AW; Hers I
J Biol Chem; 2013 Feb; 288(6):3918-28. PubMed ID: 23239877
[TBL] [Abstract][Full Text] [Related]
56. Endoplasmic reticulum stress-induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol 3-kinase/Akt and increased glycogen synthase kinase-3beta in mouse insulinoma cells.
Srinivasan S; Ohsugi M; Liu Z; Fatrai S; Bernal-Mizrachi E; Permutt MA
Diabetes; 2005 Apr; 54(4):968-75. PubMed ID: 15793234
[TBL] [Abstract][Full Text] [Related]
57. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.
Dutton A; Reynolds GM; Dawson CW; Young LS; Murray PG
J Pathol; 2005 Mar; 205(4):498-506. PubMed ID: 15714459
[TBL] [Abstract][Full Text] [Related]
58. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
Koga T; Hedrich CM; Mizui M; Yoshida N; Otomo K; Lieberman LA; Rauen T; Crispín JC; Tsokos GC
J Clin Invest; 2014 May; 124(5):2234-45. PubMed ID: 24667640
[TBL] [Abstract][Full Text] [Related]
59. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
[TBL] [Abstract][Full Text] [Related]
60. Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking IκB kinase activity.
Singhal E; Sen P
Int J Biochem Cell Biol; 2011 Aug; 43(8):1134-46. PubMed ID: 21536148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
